Overview
Availability
- Dr Ranran Zhang is:
- Available for supervision
Qualifications
- Masters (Research) of Clinical Medicine, Guangzhou Medical University
- Doctor of Philosophy of Biomedicine, Cell Biology, The University of Queensland
Works
Search Professor Ranran Zhang’s works on UQ eSpace
2024
Conference Publication
3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS
Bywater, Megan, Zhang, Ranran, Grabek, Julian, Halder, Rohit, Janardhanan, Yashaswini, Cooper, Leanne, Cooper, Emily, Ross, David, Straube, Jasmin and Lane, Steven (2024). 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS. EXPHEM 2024, Philadelphia, PA, United States: Elsevier BV. doi: 10.1016/j.exphem.2024.104357
2024
Other Outputs
CRISPR-Cas9 approaches to model Myeloproliferative Neoplasms in vivo
Zhang, Ranran (2024). CRISPR-Cas9 approaches to model Myeloproliferative Neoplasms in vivo. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/0e84c4b
2023
Conference Publication
Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model
Zhang, Ranran, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Jaquelin, Sebastien, Straube, Jasmin, Bywater, Megan and Lane, Steven W. (2023). Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188150
2021
Journal Article
Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia
Li, Yizhen, Yang, Wentao, Devidas, Meenakshi, Winter, Stuart S., Kesserwan, Chimene, Yang, Wenjian, Dunsmore, Kimberly P., Smith, Colton, Qian, Maoxiang, Zhao, Xujie, Zhang, Ranran, Gastier-Foster, Julie M., Raetz, Elizabeth A., Carroll, William L., Li, Chunliang, Liu, Paul P., Rabin, Karen R., Sanda, Takaomi, Mullighan, Charles G., Nichols, Kim E., Evans, William E., Pui, Ching-Hon, Hunger, Stephen P., Teachey, David T., Relling, Mary, Loh, Mignon L. and Yang, Jun J. (2021). Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. Journal of Clinical Investigation, 131 (17) e147898, 1-14. doi: 10.1172/jci147898
2020
Journal Article
4-hydroxyphenyl retinamide preferentially targets FLT3 mutated acute myeloid leukemia via ROS induction and NF-kappa B inhibition
Zhao, Xin-ying, Zhang, Ran-ran, Ye, Qian, Qiu, Fei, Xu, Hao-yu, Wei, Feng-gui and Zhang, Hui (2020). 4-hydroxyphenyl retinamide preferentially targets FLT3 mutated acute myeloid leukemia via ROS induction and NF-kappa B inhibition. Current Medical Science, 40 (5), 810-816. doi: 10.1007/s11596-020-2259-0
2020
Journal Article
Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells
Zhang, Hui, Xu, Haoyu, Zhang, Ranran, Zhao, Xinying, Liang, Ming and Wei, Fenggui (2020). Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells. Cancer Chemotherapy and Pharmacology, 86 (2), 257-266. doi: 10.1007/s00280-020-04115-y
2019
Conference Publication
Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children
Li, Yizhen, Qian, Maoxiang, Devidas, Meenakshi, Yang, Wentao, Winter, Stuart S., Dunsmore, Kimberly P., Smith, Colton A., Lin, Ting-Nien, Zhao, Xuijie, Zhang, Ranran, Foster, Julie M. Gastier, Raetz, Elizabeth A., Carroll, William L., Rabin, Karen R., Yang, Wenjian, Zweidler-McKay, Patrick A., Pui, Ching-Hon, Evans, William E., Mullighan, Charles G., Hunger, Stephen P., Relling, Mary V., Loh, Mignon L. and Yang, Jun J. (2019). Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children. 61st Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, United States, 7-10 December 2019. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2019-125912
2018
Journal Article
Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia
Churchman, Michelle L., Qian, Maoxiang, te Kronnie, Geertruy, Zhang, Ranran, Yang, Wenjian, Zhang, Hui, Lana, Tobia, Tedrick, Paige, Baskin, Rebekah, Verbist, Katherine, Peters, Jennifer L., Devidas, Meenakshi, Larsen, Eric, Moore, Ian M., Gu, Zhaohui, Qu, Chunxu, Yoshihara, Hiroki, Porter, Shaina N., Pruett-Miller, Shondra M., Wu, Gang, Raetz, Elizabeth, Martin, Paul L., Bowman, W. Paul, Winick, Naomi, Mardis, Elaine, Fulton, Robert, Stanulla, Martin, Evans, William E., Relling, Mary V. ... Mullighan, Charles G. (2018). Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell, 33 (5), 937-948. doi: 10.1016/j.ccell.2018.03.021
2017
Journal Article
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP
Qian, Maoxiang, Zhang, Hui, Kham, Shirley Kow-Yin, Liu, Shuguang, Jiang, Chuang, Zhao, Xujie, Lu, Yi, Goodings, Charnise, Lin, Ting-Nien, Zhang, Ranran, Moriyama, Takaya, Yin, Zhaohong, Li, Zhenhua, Quah, Thuan Chong, Ariffin, Hany, Tan, Ah Moy, Shen, Shuhong, Bhojwani, Deepa, Hu, Shaoyan, Chen, Suning, Zheng, Huyong, Pui, Ching-Hon, Yeoh, Allen Eng-Juh and Yang, Jun J. (2017). Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Research, 27 (2), 185-195. doi: 10.1101/gr.209163.116
2016
Conference Publication
Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy
Zhang, Ranran, Fenggui, Wei, Chen, Ru, Liang, Ming, Wu, Liping, Zhang, Hui and Chen, Fuxiong (2016). Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy. 58th ASH Annual Meeting, San Diego, CA United States, 3-6 December 2016. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v128.22.1580.1580
2015
Journal Article
Research progress on chemoresistance mechanism of nuclear factor kappa B signalling patheway in acute myeloid leukemia
Zhang, Ran-Ran, Zhang, Hui and Chen, Fu-Xiong (2015). Research progress on chemoresistance mechanism of nuclear factor kappa B signalling patheway in acute myeloid leukemia. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, 23 (6), 1785-1790. doi: 10.7534/j.issn.1009-2137.2015.06.046
Supervision
Availability
- Dr Ranran Zhang is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Dr Ranran Zhang's areas of expertise, story ideas and help finding experts, contact our Media team: